Company Valuation: Mesa Laboratories, Inc.

Data adjusted to current consolidation scope
Fiscal Period: March 2022 2023 2024 2025 2026 2027 2028
Market Cap 1 1,337 934.1 591.9 644.8 488.5 564.1 -
Change - -30.14% -36.64% 8.93% -24.23% 15.48% -
Enterprise Value (EV) 1,506 1,084 591.9 644.8 488.5 564.1 564.1
Change - -27.99% -45.42% 8.93% -24.23% 15.48% 0%
P/E 728x 1,028x -2.32x -330x 73.1x 74.1x 47x
PBR 3.41x 2.38x 4.07x 4.05x 2.62x 2.69x 2.49x
PEG - -20x 0x 3.3x -0x 6x 0.8x
Capitalization / Revenue 7.25x 4.26x 2.74x 2.68x 1.96x 2.18x 2.07x
EV / Revenue 0x 0x 0x 0x 0x 2.18x 2.07x
EV / EBITDA 0x 0x 0x 0x 0x 8.93x 8.41x
EV / EBIT 0x 0x 0x 0x 0x 8.59x 8.01x
EV / FCF 0x 0x 0x 0x 0x 14.1x 12.7x
FCF Yield 2.6% 2.51% 7.02% 6.6% 8.1% 7.09% 7.85%
Dividend per Share 2 0.64 0.64 0.64 0.64 0.64 0.64 0.64
Rate of return 0.25% 0.37% 0.58% 0.54% 0.72% 0.63% 0.63%
EPS 2 0.35 0.17 -47.2 -0.36 1.21 1.36 2.143
Distribution rate 183% 376% -1.36% -178% 52.9% 47.1% 29.9%
Net sales 1 184.3 219.1 216.2 241 249.1 259.2 272.2
EBITDA 1 41.16 49.68 50.5 56.74 63.49 63.2 67.1
EBIT 1 37.9 45.82 50.5 51.36 58.23 65.7 70.4
Net income 1 1.871 0.93 -254.2 -1.974 6.712 7.567 12.13
Net Debt 169 150.4 - - - - -
Reference price 2 254.88 174.73 109.73 118.66 88.42 100.81 100.81
Nbr of stocks (in thousands) 5,246 5,346 5,394 5,434 5,525 5,596 -
Announcement Date 31/5/22 25/5/23 5/6/24 28/5/25 27/5/26 - -
1USD in Million2USD
Estimates

P/E, Detailed evolution

P/E (N) EV / Sales (N) EV / EBITDA (N) Dividend Yield (N) Capi.($)
74.29x - - 0.63% 564M
30.24x4.11x15.98x2.44% 183B
19.42x3.39x11.94x3.47% 109B
17.37x0.19x12.26x0.76% 60.57B
30.04x7.29x19x1.33% 51.8B
36.03x3.22x10.97x2.37% 45.64B
37.5x1.37x12.06x0.21% 33.22B
30.28x5.41x17.22x-.--% 31.49B
39.6x6.94x24.84x0.27% 24B
24.62x3.73x13.08x1.13% 22.26B
Average 33.94x 3.96x 15.26x 1.26% 56.17B
Weighted average by Cap. 27.85x 3.79x 14.76x 1.94%

Y-o-Y evolution of P/E

Historical PBR trend

Evolution Enterprise Value / Sales

Change in Enterprise Value/EBITDA

Year-on-year evolution of the Yield

  1. Stock Market
  2. Stocks
  3. MLAB Stock
  4. Valuation Mesa Laboratories, Inc.